• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

CFTC Supports Gemini's Request for Judgment Relief

chest

The CFTC announced its support for Gemini's request to the court to relieve the exchange from a judgment related to a case filed in 2022.

user avatarJacob Williams

Sharplink Also Joins Russell 2000 and 3000 Indexes

chest

Sharplink has been included in the Russell 2000 and 3000 indexes, validating its Ethereum treasury strategy.

user avatarSon Min-ho

Forward Industries to Join Russell 2000 and 3000 Indexes

chest

Forward Industries is set to join the Russell 2000 and 3000 indexes, enhancing its visibility and credibility in the market.

user avatarZainab Kamara

Bitcoin Trading Volumes Plummet Amid Market Conditions

chest

Bitcoin spot trading volumes have collapsed by approximately 81% since October 2025, reflecting unfavorable market conditions.

user avatarKofi Adjeman

Senator Lummis Issues Urgent Warning for Software Developers Amid CLARITY Act Delays

chest

Senator Cynthia Lummis warns software developers about the risks they face without the CLARITY Act, which aims to provide a clearer regulatory framework for the crypto industry.

user avatarAyman Ben Youssef

Bitcoin's Security Model Faces Quantum Computing Risks

chest

New data reveals potential vulnerabilities in Bitcoin's security model due to quantum computing advancements.

user avatarTando Nkube

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.